These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 30799193

  • 1. Fecal bile acid profile after Roux-en-Y gastric bypass and its association with the remission of type 2 diabetes in obese women: A preliminary study.
    de Siqueira Cardinelli C, Torrinhas RS, Sala P, Pudenzi MA, Fernando F Angolini C, Marques da Silva M, Machado NM, Ravacci G, Eberlin MN, Waitzberg DL.
    Clin Nutr; 2019 Dec; 38(6):2906-2912. PubMed ID: 30799193
    [Abstract] [Full Text] [Related]

  • 2. Effect of Roux-en-Y gastric bypass surgery on bile acid metabolism in normal and obese diabetic rats.
    Bhutta HY, Rajpal N, White W, Freudenberg JM, Liu Y, Way J, Rajpal D, Cooper DC, Young A, Tavakkoli A, Chen L.
    PLoS One; 2015 Dec; 10(3):e0122273. PubMed ID: 25798945
    [Abstract] [Full Text] [Related]

  • 3. A role for fibroblast growth factor 19 and bile acids in diabetes remission after Roux-en-Y gastric bypass.
    Gerhard GS, Styer AM, Wood GC, Roesch SL, Petrick AT, Gabrielsen J, Strodel WE, Still CD, Argyropoulos G.
    Diabetes Care; 2013 Jul; 36(7):1859-64. PubMed ID: 23801799
    [Abstract] [Full Text] [Related]

  • 4. Chenodeoxycholic Acid as a Potential Prognostic Marker for Roux-en-Y Gastric Bypass in Chinese Obese Patients.
    Yu H, Ni Y, Bao Y, Zhang P, Zhao A, Chen T, Xie G, Tu Y, Zhang L, Su M, Wei L, Jia W, Jia W.
    J Clin Endocrinol Metab; 2015 Nov; 100(11):4222-30. PubMed ID: 26425885
    [Abstract] [Full Text] [Related]

  • 5. Changes in Bile Acid Metabolism, Transport, and Signaling as Central Drivers for Metabolic Improvements After Bariatric Surgery.
    Browning MG, Pessoa BM, Khoraki J, Campos GM.
    Curr Obes Rep; 2019 Jun; 8(2):175-184. PubMed ID: 30847736
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Increased Bile Acids and FGF19 After Sleeve Gastrectomy and Roux-en-Y Gastric Bypass Correlate with Improvement in Type 2 Diabetes in a Randomized Trial.
    Nemati R, Lu J, Dokpuang D, Booth M, Plank LD, Murphy R.
    Obes Surg; 2018 Sep; 28(9):2672-2686. PubMed ID: 29987678
    [Abstract] [Full Text] [Related]

  • 9. Influence of Roux-en-Y gastric bypass on plasma bile acid profiles: a comparative study between rats, pigs and humans.
    Spinelli V, Lalloyer F, Baud G, Osto E, Kouach M, Daoudi M, Vallez E, Raverdy V, Goossens JF, Descat A, Doytcheva P, Hubert T, Lutz TA, Lestavel S, Staels B, Pattou F, Tailleux A.
    Int J Obes (Lond); 2016 Aug; 40(8):1260-7. PubMed ID: 27089995
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Metabolomics Study of Roux-en-Y Gastric Bypass Surgery (RYGB) to Treat Type 2 Diabetes Patients Based on Ultraperformance Liquid Chromatography-Mass Spectrometry.
    Luo P, Yu H, Zhao X, Bao Y, Hong CS, Zhang P, Tu Y, Yin P, Gao P, Wei L, Zhuang Z, Jia W, Xu G.
    J Proteome Res; 2016 Apr 01; 15(4):1288-99. PubMed ID: 26889720
    [Abstract] [Full Text] [Related]

  • 12. Type 2 Diabetes Remission After Roux-en-Y Gastric Bypass: Evidence for Increased Expression of Jejunal Genes Encoding Regenerating Pancreatic Islet-Derived Proteins as a Potential Mechanism.
    Sala P, Torrinhas RS, Fonseca DC, Heymsfield S, Giannella-Neto D, Waitzberg DL.
    Obes Surg; 2017 Apr 01; 27(4):1123-1127. PubMed ID: 28213664
    [Abstract] [Full Text] [Related]

  • 13. FGF 19 and Bile Acids Increase Following Roux-en-Y Gastric Bypass but Not After Medical Management in Patients with Type 2 Diabetes.
    Sachdev S, Wang Q, Billington C, Connett J, Ahmed L, Inabnet W, Chua S, Ikramuddin S, Korner J.
    Obes Surg; 2016 May 01; 26(5):957-65. PubMed ID: 26259981
    [Abstract] [Full Text] [Related]

  • 14. Increase of the Adiponectin/Leptin Ratio in Patients with Obesity and Type 2 Diabetes after Roux-en-Y Gastric Bypass.
    Unamuno X, Izaguirre M, Gómez-Ambrosi J, Rodríguez A, Ramírez B, Becerril S, Valentí V, Moncada R, Silva C, Salvador J, Portincasa P, Frühbeck G, Catalán V.
    Nutrients; 2019 Sep 03; 11(9):. PubMed ID: 31484347
    [Abstract] [Full Text] [Related]

  • 15. Gut Microbiota Profile of Obese Diabetic Women Submitted to Roux-en-Y Gastric Bypass and Its Association with Food Intake and Postoperative Diabetes Remission.
    Al Assal K, Prifti E, Belda E, Sala P, Clément K, Dao MC, Doré J, Levenez F, Taddei CR, Fonseca DC, Rocha IM, Balmant BD, Thomas AM, Santo MA, Dias-Neto E, Setubal JC, Zucker JD, Belarmino G, Torrinhas RS, Waitzberg DL.
    Nutrients; 2020 Jan 21; 12(2):. PubMed ID: 31973130
    [Abstract] [Full Text] [Related]

  • 16. Bone Health in Patients with Type 2 Diabetes Treated by Roux-En-Y Gastric Bypass and the Role of Diabetes Remission.
    Madsen LR, Espersen R, Ornstrup MJ, Jørgensen NR, Langdahl BL, Richelsen B.
    Obes Surg; 2019 Jun 21; 29(6):1823-1831. PubMed ID: 30719648
    [Abstract] [Full Text] [Related]

  • 17. The impact of bariatric surgery on insulin-treated type 2 diabetes patients.
    Lemus R, Karni D, Hong D, Gmora S, Breau R, Anvari M.
    Surg Endosc; 2018 Feb 21; 32(2):990-1001. PubMed ID: 28842774
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Early Increases in Bile Acids Post Roux-en-Y Gastric Bypass Are Driven by Insulin-Sensitizing, Secondary Bile Acids.
    Albaugh VL, Flynn CR, Cai S, Xiao Y, Tamboli RA, Abumrad NN.
    J Clin Endocrinol Metab; 2015 Sep 21; 100(9):E1225-33. PubMed ID: 26196952
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.